ZOLEDRONIC Safety Questions, ZOLEDRONIC Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about ZOLEDRONIC. Our extensive database of ZOLEDRONIC adverse events and ZOLEDRONIC warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about ZOLEDRONIC
ZOLEDRONIC Safety Reports
Total ZOLEDRONIC reports: 196.ZOLEDRONIC FDA safety alerts: 2004 2005 2007 .
Reported deaths: 16 Reported hospitalizations: 56.
Take ZOLEDRONIC Side Effects Survey or Share Your ZOLEDRONIC Story. Read More Here.
Showing 1-50 of 196 Next >
Physician from FRANCE reported ZOLEDRONIC problem on Apr 30, 2007. Male patient, 14 years of age, weighting 120.2 lb, was diagnosed with bone sarcoma and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: electrocardiogram qt prolonged, hypocalcaemia, hypokalaemia, hyponatraemia, paraesthesia. ZOLEDRONIC dosage: 4 MG, UNK. Patient recovered.ZOLEDRONIC problem was reported by a Health Professional from UNITED KINGDOM on Apr 27, 2007. Male patient, 37 years of age, was diagnosed with osteoporosis and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: asthma, chest pain, condition aggravated, dyspnoea. ZOLEDRONIC dosage: unknown. During the same period patient was treated with AMLODIPINE, CETIRIZINE, PREDNISOLONE, VENTOLIN, VIAGRA. Patient recovered.
Physician from UNITED KINGDOM reported ZOLEDRONIC problem on May 03, 2007. Female patient, 39 years of age, weighting 127.9 lb, was diagnosed with metastases to bone, breast cancer and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: bacterial infection, bone trimming, fungal infection, impaired healing, inflammation, osteomyelitis, osteonecrosis, sequestrectomy, tooth extraction. ZOLEDRONIC dosage: 4 MG, UNK. During the same period patient was treated with VITAMIN D, CALCIUM CHLORIDE, EPIRUBICIN, CYCLOPHOSPHAMIDE, METHOTREXATE, FLUOROURACIL, GLICLAZIDE, TAMOXIFEN CITRATE. Patient was hospitalized. Patient recovered.
ZOLEDRONIC problem was reported by a Physician from BELGIUM on May 14, 2007. Female patient, 69 years of age, weighting 152.1 lb, was diagnosed with breast cancer and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: artificial crown procedure, dental caries, dental examination abnormal, gingivitis, haemorrhage, osteonecrosis, resorption bone increased, sensitivity of teeth, tooth extraction. ZOLEDRONIC dosage: 3.5 MG,. During the same period patient was treated with CACIT D, FEMARA, PREMARIN. Patient recovered.
Physician from POLAND reported ZOLEDRONIC problem on May 15, 2007. Female patient, 77 years of age, weighting 179.9 lb, was diagnosed with osteoporosis postmenopausal, hypertension and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cataract, cataract operation, concomitant disease progression, glaucoma, hepatic lesion, lens implant. ZOLEDRONIC dosage: unknown. During the same period patient was treated with CALCIUM CHLORIDE, VITAMIN D, ATENOLOL, DICLOFENAC. Patient was hospitalized. Patient recovered.
ZOLEDRONIC problem was reported by a Physician from AUSTRALIA on May 18, 2007. Female patient, 74 years of age, weighting 180.6 lb, was diagnosed with osteoporosis postmenopausal, pain in extremity, migraine and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: dysarthria, facial palsy, fall, humerus fracture, pain in extremity, transient ischaemic attack. ZOLEDRONIC dosage: unknown. During the same period patient was treated with CELEBREX, IMIGRAN, CALCIUM CHLORIDE, VITAMIN D. Patient was hospitalized. Patient recovered.
Health Professional from NETHERLANDS reported ZOLEDRONIC problem on May 23, 2007. Male patient, 69 years of age, was diagnosed with multiple myeloma and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: bone disorder, osteonecrosis, pain in jaw, tooth extraction, wound closure, wound debridement, wound dehiscence. ZOLEDRONIC dosage: 4 MG MONTHLY. Patient recovered.
ZOLEDRONIC problem was reported by a Physician from GERMANY on May 24, 2007. Female patient, weighting 125.7 lb, was diagnosed with breast cancer and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: arthropathy, arthroscopy, chondropathy, loose tooth, meniscus lesion, osteonecrosis, periodontal disease, tooth extraction. ZOLEDRONIC dosage: 4MG EVERY 3 MONTHS. During the same period patient was treated with CALCIMAGON, TAMOXIFEN, GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.
Physician from UNITED KINGDOM reported ZOLEDRONIC problem on May 24, 2007. Female patient, 58 years of age, weighting 172.6 lb, was diagnosed with metastases to bone, breast cancer, antiemetic supportive care and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: arthralgia, bone disorder, bursa disorder, gait disturbance, haemangioma, hip arthroplasty, joint stiffness, muscle disorder, osteonecrosis. ZOLEDRONIC dosage: 4 MG, UNK. During the same period patient was treated with EPIRUBICIN, DEXAMETHASONE, GRANISETRON, DOMPERIDONE. Patient was hospitalized and became disabled. Patient recovered.
ZOLEDRONIC problem was reported by a Physician from FRANCE on May 31, 2007. Male patient, 14 years of age, weighting 120.2 lb, was diagnosed with bone sarcoma and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: electrocardiogram qt prolonged, hypocalcaemia, hypokalaemia, hyponatraemia, paraesthesia. ZOLEDRONIC dosage: 4 MG, UNK. During the same period patient was treated with CALCIUM CHLORIDE, VITAMIN D. Patient recovered.
Health Professional from ITALY reported ZOLEDRONIC problem on May 25, 2007. Female patient, 76 years of age, was diagnosed with multiple myeloma and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: bone debridement, oral surgery, osteonecrosis. ZOLEDRONIC dosage: unknown. During the same period patient was treated with MELPHALAN, PREDNISONE. Patient recovered.
ZOLEDRONIC problem was reported by a Health Professional from ITALY on May 25, 2007. Female patient, 72 years of age, was diagnosed with multiple myeloma and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: bone debridement, oral surgery, osteonecrosis. ZOLEDRONIC dosage: unknown. During the same period patient was treated with PAMIDRONATE DI. Patient recovered.
Health Professional from ITALY reported ZOLEDRONIC problem on May 25, 2007. Female patient, 72 years of age, was diagnosed with multiple myeloma and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: bone debridement, osteonecrosis. ZOLEDRONIC dosage: unknown. During the same period patient was treated with MELPHALAN, PREDNISONE. Patient recovered.
ZOLEDRONIC problem was reported by a Health Professional from ITALY on May 25, 2007. Female patient, 66 years of age, was diagnosed with multiple myeloma and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: bone debridement, osteonecrosis. ZOLEDRONIC dosage: unknown. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE. Patient recovered.
Health Professional from ITALY reported ZOLEDRONIC problem on May 25, 2007. Male patient, 65 years of age, was diagnosed with multiple myeloma and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: bone debridement, oral surgery, osteonecrosis. ZOLEDRONIC dosage: unknown. During the same period patient was treated with MELPHALAN, PREDNISONE. Patient recovered.
ZOLEDRONIC problem was reported by a Health Professional from ITALY on May 25, 2007. Female patient, 76 years of age, was diagnosed with multiple myeloma and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: bone debridement, oral surgery, osteonecrosis. ZOLEDRONIC dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, MELPHALAN, PREDNISONE. Patient recovered.
Health Professional from ITALY reported ZOLEDRONIC problem on May 25, 2007. Female patient, 62 years of age, was diagnosed with multiple myeloma and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: bone debridement, dental operation, osteonecrosis. ZOLEDRONIC dosage: unknown. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, VINCRISTINE, DOXORUBICIN. Patient recovered.
ZOLEDRONIC problem was reported by a Health Professional from ITALY on May 25, 2007. Female patient, 69 years of age, was diagnosed with multiple myeloma and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: bone debridement, dental operation, osteonecrosis. ZOLEDRONIC dosage: unknown. During the same period patient was treated with PAMIDRONATE DI, MELPHALAN, PREDNISONE. Patient recovered.
Health Professional from ITALY reported ZOLEDRONIC problem on May 25, 2007. Female patient, 58 years of age, was diagnosed with multiple myeloma and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: bone debridement, osteonecrosis. ZOLEDRONIC dosage: unknown. During the same period patient was treated with PAMIDRONATE DI, VINCRISTINE, MELPHALAN, CYCLOPHOSPHAMIDE, PREDNISONE. Patient recovered.
ZOLEDRONIC problem was reported by a Physician from BELGIUM on May 31, 2007. Female patient, 69 years of age, weighting 152.1 lb, was diagnosed with breast cancer and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: artificial crown procedure, dental caries, dental examination abnormal, gingivitis, haemorrhage, osteonecrosis, resorption bone increased, sensitivity of teeth, tooth extraction. ZOLEDRONIC dosage: 3.5 MG,. During the same period patient was treated with CACIT D, FEMARA, PREMARIN. Patient recovered.
Physician from GERMANY reported ZOLEDRONIC problem on May 28, 2007. Female patient, 71 years of age, was diagnosed with metastases to bone, breast cancer and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: gastrointestinal pain, nausea, osteonecrosis, surgery. ZOLEDRONIC dosage: 4 MG, ONCE A MONTH. During the same period patient was treated with KEVATRIL, CLINDAMYCIN, TAVEGIL, PACLITAXEL, DEXAMETHASONE, CALCIUM CHLORIDE, VITAMIN D, RANITIDINE. Patient recovered.
ZOLEDRONIC problem was reported by a Physician from IRELAND on May 31, 2007. Female patient, 70 years of age, weighting 138.0 lb, was diagnosed with metastases to bone, breast cancer and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: tooth extraction. ZOLEDRONIC dosage: 4 MG, UNK. During the same period patient was treated with CALCIUM CHLORIDE, VITAMIN D, ARIMIDEX. Patient recovered.
Physician from GERMANY reported ZOLEDRONIC problem on May 29, 2007. Female patient, weighting 383.6 lb, was diagnosed with breast cancer and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: postmenopausal haemorrhage, uterine atrophy, uterine dilation and curettage. ZOLEDRONIC dosage: 4MG EVERY 3 MONTHS. During the same period patient was treated with FEMARA, CEFASEL, MARCUMAR. Patient was hospitalized. Patient recovered.
ZOLEDRONIC problem was reported by a Physician from POLAND on June 04, 2007. Female patient, 77 years of age, weighting 179.9 lb, was diagnosed with osteoporosis postmenopausal, hypertension, varicose ulceration and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cataract, cataract operation, chorioretinopathy, concomitant disease progression, glaucoma, hepatic lesion. ZOLEDRONIC dosage: unknown. During the same period patient was treated with CALCIUM CHLORIDE, VITAMIN D, ATENOLOL, DICLOFENAC. Patient was hospitalized. Patient recovered.
Physician from AUSTRALIA reported ZOLEDRONIC problem on June 06, 2007. Female patient, 63 years of age, weighting 163.0 lb, was diagnosed with metastases to bone and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: gingival infection, osteomyelitis, osteonecrosis, pain in jaw, tooth extraction. ZOLEDRONIC dosage: 4 MG. During the same period patient was treated with ARIMIDEX, OSTELIN, PERINDOPRIL ERBUMINE, CALCIUM CHLORIDE, VITAMIN D. Patient recovered.
ZOLEDRONIC problem was reported by a Physician from AUSTRALIA on June 06, 2007. Female patient, 63 years of age, weighting 163.0 lb, was diagnosed with metastases to bone and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: gingival infection, osteomyelitis, osteonecrosis, pain in jaw, tooth extraction. ZOLEDRONIC dosage: 4 MG. During the same period patient was treated with ARIMIDEX, OSTELIN, PERINDOPRIL ERBUMINE, CALCIUM CHLORIDE, VITAMIN D. Patient recovered.
Physician from reported ZOLEDRONIC problem on June 13, 2007. Male patient, 60 years of age, weighting 174.2 lb, was diagnosed with metastases to bone and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: atrial flutter, burning sensation, condition aggravated, dental treatment, disorder of orbit, dyspnoea, ear disorder, erythema, face oedema. ZOLEDRONIC dosage: 4MG EVERY 4WEEKS. During the same period patient was treated with CALCIUM CHLORIDE, VITAMIN D, TRIPTORELIN ACETATE, CYPROTERONE ACETATE. Patient was hospitalized and became disabled. Patient recovered.
ZOLEDRONIC problem was reported by a Physician from UNITED KINGDOM on June 11, 2007. Female patient, weighting 136.7 lb, was diagnosed with metastases to bone and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: gingivitis, oedema mouth, osteonecrosis, pain in jaw, sequestrectomy, tooth extraction. ZOLEDRONIC dosage: 4 MG, UNK. Patient recovered.
Physician from TAIWAN, PROVINCE OF CHINA reported ZOLEDRONIC problem on June 15, 2007. Male patient, 69 years of age, weighting 180.8 lb, was diagnosed with metastases to bone and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, angina unstable, catheterisation cardiac, chest discomfort, coronary arterial stent insertion, coronary artery disease. ZOLEDRONIC dosage: 4MG EVERY 3-4 WEEKS. During the same period patient was treated with CALCIUM CHLORIDE, VITAMIN D. Patient was hospitalized. Patient recovered.
ZOLEDRONIC problem was reported by a Physician from MEXICO on June 13, 2007. Male patient, 75 years of age, weighting 120.2 lb, was diagnosed with metastases to bone, prostate cancer and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: asthenia, dehydration, disease progression, mouth ulceration, mucosal inflammation, neutropenia, pancytopenia, platelet count decreased, pneumonia. ZOLEDRONIC dosage: 0.4 MG, Q4W. During the same period patient was treated with CALCIUM CHLORIDE, VITAMIN D, DOCETAXEL. Patient was hospitalized. Patient died on 04/19/2006.
Health Professional from UNITED STATES reported ZOLEDRONIC problem on June 20, 2006. Female patient, 69 years of age, was diagnosed with metastases to bone and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: bone disorder, bone lesion excision, dental caries, oral surgery, osteitis, osteonecrosis, pain, plastic surgery. ZOLEDRONIC dosage: unknown. Patient recovered.
ZOLEDRONIC problem was reported by a Physician from UNITED STATES on May 16, 2006. Female patient, 73 years of age, weighting 162.3 lb, was diagnosed with metastases to bone and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: acidosis, acute myocardial infarction, arteriosclerosis coronary artery, atrioventricular block first degree, blood creatinine increased, blood culture positive, blood pressure increased, brain natriuretic peptide increased, cardiac failure congestive. ZOLEDRONIC dosage: 4 MG, QMO. During the same period patient was treated with CALCIUM GLUCONATE, VITAMIN D, ASPIRIN, COREG, TRICOR, FOLTX, LASIX, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient died on 06/07/2006.
Physician from TAIWAN, PROVINCE OF CHINA reported ZOLEDRONIC problem on June 15, 2006. Male patient, 66 years of age, weighting 266.8 lb, was diagnosed with metastases to bone and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, decreased appetite, dyspepsia, flank pain, hydronephrosis, hyperkalaemia, hyperlipidaemia, malignant neoplasm progression, nausea. ZOLEDRONIC dosage: 4 MG EVERY 3-4 WEEKS. During the same period patient was treated with CALCIUM GLUCONATE, VITAMIN D, MEPERIDINE. Patient was hospitalized. Patient recovered.
ZOLEDRONIC problem was reported by a Consumer or non-health professional from ITALY on Apr 07, 2005. Female patient, 65 years of age, was diagnosed with multiple myeloma and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: autoimmune disorder, blood thyroid stimulating hormone increased, primary hypothyroidism, thyroxine free decreased. ZOLEDRONIC dosage: 4 MG, QMO. During the same period patient was treated with PEGASYS. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported ZOLEDRONIC problem on July 13, 2006. Female patient, 53 years of age, weighting 207.7 lb, was diagnosed with metastases to bone and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: bacterial infection, gingival abscess, osteomyelitis, osteonecrosis, tooth extraction. ZOLEDRONIC dosage: 4 MG, UNK. Patient was hospitalized and became disabled. Patient recovered.
ZOLEDRONIC problem was reported by a Consumer or non-health professional from CANADA on July 20, 2006. Female patient was diagnosed with osteoporosis and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. ZOLEDRONIC dosage: 4 MG EVERY 3 MONTHS. During the same period patient was treated with VITAMIN D, CALCIUM GLUCONATE. Patient recovered.
Physician from UNITED STATES reported ZOLEDRONIC problem on June 13, 2006. Male patient, 69 years of age, weighting 319.7 lb, was diagnosed with osteoporosis and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: atelectasis, gastric ulcer, gastritis, gastrointestinal haemorrhage, haematochezia, oesophageal stenosis, oesophagitis, pneumonia. ZOLEDRONIC dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, VITAMIN D. Patient was hospitalized. Patient recovered.
ZOLEDRONIC problem was reported by a Health Professional from POLAND on Aug 10, 2006. Female patient, 55 years of age, was diagnosed with multiple myeloma and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: bone debridement, bone disorder, dental caries, denture wearer, osteonecrosis, pain in jaw, pancytopenia, sepsis, tooth extraction. ZOLEDRONIC dosage: 4 MG, EVERY MONTH. During the same period patient was treated with CYCLOPHOSPHAMIDE W, MELPHALAN, ADRIAMYCINE, CARMUSTINE, PREDNISONE. Patient died.
Physician from UNITED KINGDOM reported ZOLEDRONIC problem on Aug 15, 2006. Female patient, 67 years of age, was diagnosed with breast cancer and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: dental treatment, infection, osteonecrosis, pain. ZOLEDRONIC dosage: 4MG. During the same period patient was treated with EXEMESTANE. Patient recovered.
ZOLEDRONIC problem was reported by a Physician from AUSTRALIA on Aug 01, 2006. Female patient, 68 years of age, was diagnosed with multiple myeloma and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: dental caries, oral pain, osteonecrosis, tooth extraction. ZOLEDRONIC dosage: 4 MG, QMO. During the same period patient was treated with PREDNISOLONE, THALIDOMIDE. Patient recovered.
Physician from UNITED KINGDOM reported ZOLEDRONIC problem on July 11, 2006. Male patient, 80 years of age, was diagnosed with prostate cancer, pain and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: pain in jaw. ZOLEDRONIC dosage: 4MG/DAY. During the same period patient was treated with CASODEX, PARACETAMOL, DICLOFENAC, BISPHOSPHONATES. Patient recovered.
ZOLEDRONIC problem was reported by a Physician from AUSTRALIA on Aug 01, 2006. Female patient, 68 years of age, was diagnosed with multiple myeloma and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: dental caries, oral pain, osteonecrosis, tooth extraction. ZOLEDRONIC dosage: 4 MG, QMO. During the same period patient was treated with PREDNISOLONE, THALIDOMIDE. Patient recovered.
Health Professional from ITALY reported ZOLEDRONIC problem on Sept 07, 2006. Male patient, 73 years of age, was diagnosed with multiple myeloma and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: infection, osteonecrosis, surgery. ZOLEDRONIC dosage: unknown. Patient recovered.
ZOLEDRONIC problem was reported by a Health Professional from ITALY on Sept 07, 2006. Female patient, 64 years of age, was diagnosed with breast cancer and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: alveoloplasty, dental treatment, gingival operation, impaired healing, infection, osteonecrosis, tooth extraction. ZOLEDRONIC dosage: unknown. During the same period patient was treated with TAMOXIFEN CITRATE, CYCLOPHOSPHAMIDE, LETROZOLE. Patient recovered.
Health Professional from ITALY reported ZOLEDRONIC problem on Sept 07, 2006. Female patient, 72 years of age, was diagnosed with lung neoplasm malignant and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: infection, osteonecrosis, sequestrectomy. ZOLEDRONIC dosage: unknown. During the same period patient was treated with GEMCITABINE, CISPLATIN, PACLITAXEL, DOCETAXEL, GEFITINIB. Patient recovered.
ZOLEDRONIC problem was reported by a Health Professional from ITALY on Sept 07, 2006. Female patient, 70 years of age, was diagnosed with multiple myeloma and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: infection, osteonecrosis, surgery. ZOLEDRONIC dosage: unknown. Patient recovered.
Consumer or non-health professional from ITALY reported ZOLEDRONIC problem on Sept 07, 2006. Female patient, 78 years of age, was diagnosed with breast cancer and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: infection, osteonecrosis, surgery. ZOLEDRONIC dosage: unknown. During the same period patient was treated with TAMOXIFEN CITRATE, CYCLOPHOSPHAMIDE, LETROZOLE. Patient recovered.
ZOLEDRONIC problem was reported by a Health Professional from ITALY on Sept 07, 2006. Female patient, 63 years of age, was diagnosed with breast cancer and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: infection, osteonecrosis. ZOLEDRONIC dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, TAMOXIFEN CITRATE, LETROZOLE. Patient recovered.
Health Professional from ITALY reported ZOLEDRONIC problem on Sept 07, 2006. Female patient, 78 years of age, was diagnosed with breast cancer and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: infection, osteonecrosis, sequestrectomy. ZOLEDRONIC dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, TAMOXIFEN CITRATE, LETROZOLE. Patient recovered.
ZOLEDRONIC problem was reported by a Health Professional from ITALY on Sept 07, 2006. Female patient, 58 years of age, was diagnosed with breast cancer and was treated with ZOLEDRONIC. After drug was administered, patient experienced the following problems/side effects: infection, osteonecrosis, surgery. ZOLEDRONIC dosage: unknown. During the same period patient was treated with TAMOXIFEN CITRATE, LETROZOLE, METHOTREXATE. Patient recovered.
Showing 1-50 of 196 Next >